Results 171 to 180 of about 14,229 (206)
Some of the next articles are maybe not open access.

Hepatorenal syndrome

The International Journal of Biochemistry & Cell Biology, 2004
Hepatorenal syndrome (HRS) is a major complication of patients with cirrhosis, with the annual incidence in patients with ascites being approximately 8% []. This syndrome develops in the latest phase of the disease and there is now evidence that it is an important determinant of patient survival.
Mónica, Guevara, Juan, Rodés
openaire   +2 more sources

The hepatorenal syndrome

Pediatric Nephrology, 1996
Hepatorenal syndrome may occur in any form of severe liver disease. It appears less common in children than adults, but still carries a poor prognosis. There are several factors involved in its aetiology, including a decreased renal perfusion pressure, activation of the renal sympathetic nervous system and increased synthesis of several vasoactive ...
G, Van Roey, K, Moore
openaire   +2 more sources

Hepatorenal Syndrome

Southern Medical Journal, 2010
Acute kidney injury (AKI) secondary to hepatorenal syndrome (HRS) is an ominous complication of end-stage liver disease (ESLD). In HRS, splanchnic and peripheral vasodilatation with reduction in effective arterial volume causes activation of mechanisms leading to intense renal vasoconstriction and functional AKI. HRS is a diagnosis of exclusion and all
Deepak, Venkat, K K, Venkat
openaire   +2 more sources

Cardiogenic Hepatorenal Syndrome

Angiology, 1990
A variant of hepatorenal syndrome occurring in patients with chronic conges tive heart failure following an episode of cardiogenic pulmonary edema, and in the absence of hypotension, is described. This was observed in 13 patients during an eleven-year period.
J E, Naschitz, D, Yeshurun, J, Shahar
openaire   +2 more sources

Hepatorenal Syndrome

1984
Renal failure without apparent cause (the hepatorenal syndrome) may develop in the course of cirrhosis of the liver. While the development of renal failure bears a poor prognosis, spontaneous recovery can occur. The data suggest that for the most part patients die in rather than of renal failure.
openaire   +2 more sources

Captopril in the Hepatorenal Syndrome

Journal of Clinical Gastroenterology, 1985
Five patients with hepatorenal syndrome were treated with the orally active angiotensin-converting enzyme inhibitor captopril (25 or 50 mg 6 hourly) for up to 48 hours. Only one patient showed a significant increase in urinary sodium concentration (from less than 10 to 70 mmol/liter), but without associated diuresis; renal function continued to ...
I, Cobden   +3 more
openaire   +2 more sources

PATHOGENESIS OF THE HEPATORENAL SYNDROME

Annual Review of Medicine, 1987
This review examines current understanding about the patient with moderately advanced cirrhosis of the liver and his or her transition to hepatorenal syndrome (HRS). Special emphasis is given to three areas of ongoing research. Atrial natriuretic factor's role in the pathogenesis of salt and water retention is examined, as well as its role in ...
E W, Davidson, M J, Dunn
openaire   +2 more sources

The Hepatorenal Syndrome

Medical Clinics of North America, 2008
The onset of renal failure in a patient with cirrhosis or acute liver failure is alarming because it raises the possibility of the hepatorenal syndrome (HRS). Periodic surveillance of renal function is helpful in patients with severe liver disease to detect HRS early and to help correct reversible contributing factors.
openaire   +2 more sources

Terlipressin for hepatorenal syndrome

2006
Terlipressin may reverse some of the circulatory changes associated with hepatorenal syndrome.To assess the beneficial and harmful effects of terlipressin for hepatorenal syndrome.Electronic searches in The Cochrane Hepato-Biliary Group Controlled Trials Register, The Cochrane Renal Group Register, the Cochrane Central Register of Controlled Trials in ...
L L, Gluud, M S, Kjaer, E, Christensen
openaire   +2 more sources

Dopamine in the Hepatorenal Syndrome

JAMA: The Journal of the American Medical Association, 1977
DOPAMINE hydrochloride has been reported to increase both renal plasma flow and, to a small extent, urinary sodium excretion in patients with the hepatorenal syndrome, but to have no notable effect on glomerular filtration rate or urinary output.
openaire   +2 more sources

Home - About - Disclaimer - Privacy